Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates?
about
CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifenLeft truncation, susceptibility, and bias in occupational cohort studiesPREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancerCommon variants at 19p13 are associated with susceptibility to ovarian cancer.Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studiesA genome-wide association study of prognosis in breast cancer.Common germ-line polymorphism of C1QA and breast cancer survivalAssociation between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survivalThe role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testingAnnexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance.Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancerThe role of genetic breast cancer susceptibility variants as prognostic factors.Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape.Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study.CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer.A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival.Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients.Mortality in persons with mental disorders is substantially overestimated using inpatient psychiatric diagnoses.Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association ConsortiumVariants in interleukin family of cytokines genes influence clearance of high risk HPV in HIV-1 coinfected African-American adolescents.Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival.A role for XRCC2 gene polymorphisms in breast cancer risk and survival.Obesity and the outcome of young breast cancer patients in the UK: the POSH study.Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue.Deconstructing the smoking-preeclampsia paradox through a counterfactual framework.Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort.Family history and outcome of young patients with breast cancer in the UK (POSH study).Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancerNew insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes.Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study.Body mass index and breast cancer survival: a Mendelian randomization analysis.Association of Prehospital Blood Product Transfusion During Medical Evacuation of Combat Casualties in Afghanistan With Acute and 30-Day Survival.
P2860
Q21195205-6CCBFB4B-D457-4E9A-AD30-B798EB759233Q23916003-0651A358-F01A-4540-80D1-1A8225CD5EC7Q24600928-CCDC3405-AF24-45F9-9693-5D03BF123454Q29417145-ACBFE00A-62E2-43D2-831F-680D6A823BFCQ33593016-0E446504-622F-4F23-8D90-13ABA9241FC3Q33780746-D3069564-7500-4BB8-83C2-A2774CEB9C8EQ33794903-1248E2BB-3035-4028-9312-6306C77CAB2EQ33828680-9723A2E9-95CB-49FF-B127-26D77079638FQ35024008-0C764C75-48B1-4016-B77F-24C19569F10AQ35681656-1405D3E2-4268-4937-BE03-4F44D1DAB430Q35889609-D042B5F7-B681-4853-8024-390744BF3C17Q36001510-4CC939F6-52E8-47A8-B3C3-3A034D030950Q36142060-0646D70C-371D-470A-BCAA-B53B67EB0AA9Q36210166-8A8B3EDC-0EC3-4131-B16C-7D62D306842DQ36347067-82B65FD0-CE84-4E70-B93C-362941B83C54Q36375358-F496BE27-5F80-418D-9996-8609B96F8EBCQ36449203-FA72C1C1-32F7-4F7E-92D2-6855075000EDQ36600132-4FBBBF11-AA7F-45DB-A762-AE3DAC0E24F5Q36696957-347F205A-385E-4B63-B86B-00102733C459Q37052173-9FE0E674-00AC-4A84-B3A6-C8CF9A41A6B6Q37102815-9D044C3D-8333-41AC-95F6-E8937A831150Q37307937-DAEEBEA0-1E43-4783-A67D-CEDE08D34C2BQ37347357-49F0F79B-543E-40B3-BF01-2B01C4DED24DQ37401549-153C576B-CB71-4E8A-958B-858BE45E04EBQ37599352-809895DD-6C78-4815-842C-2603FCD91B90Q38303253-50815FB5-CB6A-4315-9276-47A0821F668DQ38405561-5B53D006-966E-46D3-921E-AF0C1ED9ACB4Q38895349-3BE28D4C-EF98-4444-9429-68B8AF9C502FQ39019894-10573424-0D42-4AF0-9D3D-884117F16D87Q40923313-31046C65-735B-4CFD-A267-91FF7D334975Q41695706-6C01246F-C61C-4D12-9D15-23CA120B40DFQ41702637-9FF836E5-8E82-4698-9456-475CC7120496Q44358008-149141BC-879D-46AB-8553-2A780731E980Q46115524-A066DA05-66B9-43E2-A37F-C1A213C36448Q47549170-54D5A22B-E015-49CC-93D9-63E6381A2B6A
P2860
Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevalent cases in observation ...... y bias hazard ratio estimates?
@en
Prevalent cases in observation ...... y bias hazard ratio estimates?
@nl
type
label
Prevalent cases in observation ...... y bias hazard ratio estimates?
@en
Prevalent cases in observation ...... y bias hazard ratio estimates?
@nl
prefLabel
Prevalent cases in observation ...... y bias hazard ratio estimates?
@en
Prevalent cases in observation ...... y bias hazard ratio estimates?
@nl
P2093
P2860
P356
P1476
Prevalent cases in observation ...... y bias hazard ratio estimates?
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605062
P407
P577
2009-04-28T00:00:00Z